About BRAINSTORM CELL THERAPEUTICS INC
BrainStorm is a clinical-stage biotechnology company focused on developing autologous cellular therapeutics for neurodegenerative diseases. The company has received FDA agreement on a Special Protocol Assessment (SPA) for a Phase 3b trial of NurOwn® in ALS.
Development of autologous cellular therapeuticsProduction of MSC-NTF cellsConducting clinical trials for neurodegenerative diseases
Is this your company?
Claim BRAINSTORM CELL THERAPEUTICS INC to unlock the federal & state contracts GovIntel's AI has matched to you right now — plus your own scored past-performance, who you're up against, and who's risky to team with.
Claim BRAINSTORM CELL THERAPEUTICS INC & see your matchesFree to claim. Takes about a minute.
Data compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate, or want this page removed? Request a correction or removal.